Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
出版年份 2014 全文链接
标题
Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
作者
关键词
-
出版物
OncoImmunology
Volume 4, Issue 8, Pages e970462
出版商
Informa UK Limited
发表日期
2014-10-31
DOI
10.4161/21624011.2014.970462
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Few Foxp3+regulatory T cells are sufficient to protect adult mice from lethal autoimmunity
- (2014) Christian T. Mayer et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Decreased Pathology and Prolonged Survival of Human DC-SIGN Transgenic Mice during Mycobacterial Infection
- (2014) M. Schaefer et al. JOURNAL OF IMMUNOLOGY
- Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg
- (2013) A. S. Baur et al. BLOOD
- The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trials
- (2013) Sebastian P Haen et al. CURRENT OPINION IN IMMUNOLOGY
- In vivo targeting of human DC-SIGN drastically enhances CD8+T-cell-mediated protective immunity
- (2013) Christina Hesse et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy
- (2013) Paula D. Bos et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The physiological role of DC-SIGN: A tale of mice and men
- (2013) Juan J. Garcia-Vallejo et al. TRENDS IN IMMUNOLOGY
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells
- (2012) Wendy W.J. Unger et al. JOURNAL OF CONTROLLED RELEASE
- Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells
- (2012) Juan J. García-Vallejo et al. MOLECULAR IMMUNOLOGY
- Targeting regulatory T cells
- (2012) Christine Ménétrier-Caux et al. Targeted Oncology
- Targeting Dendritic Cells in vivo for Cancer Therapy
- (2012) Irina Caminschi et al. Frontiers in Immunology
- Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity
- (2012) Christian T. Mayer et al. Frontiers in Immunology
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
- (2011) Daniel T. Fisher et al. JOURNAL OF CLINICAL INVESTIGATION
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
- (2010) R. Bos et al. CANCER RESEARCH
- Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
- (2010) K. Klages et al. CANCER RESEARCH
- Analysis of the T-Cell Receptor Repertoires of Tumor-Infiltrating Conventional and Regulatory T Cells Reveals No Evidence for Conversion in Carcinogen-Induced Tumors
- (2010) J. P. Hindley et al. CANCER RESEARCH
- Conditional Regulatory T-Cell Depletion Releases Adaptive Immunity Preventing Carcinogenesis and Suppressing Established Tumor Growth
- (2010) M. W. L. Teng et al. CANCER RESEARCH
- Efficient Treg depletion induces T-cell infiltration and rejection of large tumors
- (2010) Xingrui Li et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Regulatory T cells in tumor immunity
- (2010) Hiroyoshi Nishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro
- (2010) Luis J. Cruz et al. JOURNAL OF CONTROLLED RELEASE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
- (2009) I. Kryczek et al. CANCER RESEARCH
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation
- (2009) Satwinder Kaur Singh et al. MOLECULAR IMMUNOLOGY
- Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
- (2008) M. A. Morse et al. BLOOD
- Tuning Microenvironments: Induction of Regulatory T Cells by Dendritic Cells
- (2008) Yasmine Belkaid et al. IMMUNITY
- Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma
- (2008) Jeffrey A. Sosman et al. JOURNAL OF CLINICAL ONCOLOGY
- Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
- (2008) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Engineered lentivector targeting of dendritic cells for in vivo immunization
- (2008) Lili Yang et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now